tagitanlimab   Click here for help

GtoPdb Ligand ID: 13795

Synonyms: A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167
Approved drug Immunopharmacology Ligand
tagitanlimab is an approved drug
Compound class: Antibody
Comment: Tagitanlimab (KL-A167) is a humanized anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody [1]. It is designed to block the inhibitory PD-1/PD-L1 immune checkpoint and restore anti-tumour immunity.
Bioactivity Comments
We have been unable to discover quantitative data that supports interaction of the compound with its primary molecular target.
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
programmed cell death 1 ligand 1 Primary target of this compound Hs Antibody Binding - - -
⤷